Pharma Journalist - Page 696 of 834 -

Axcynsis Receives FDA Clearance for IND of AT03-65, CLDN6-Targeting ADC

FDA Approves Lilly’s Omvoh for Crohn’s Disease, Expanding IBD Treatment Options

AbbVie and Simcere Zaiming Partner to Develop Trispecific Antibody for Multiple Myeloma

Shawn M. Cross appointed CEO of GT Biopharma

FDA commissioner Scott Gottlieb issues statement on influenza vaccine

Arrowhead sought MEDSAFE for ARO-HBV study

Aravive Biologics begins Phase 1 Clinical Trial of AVB-S6-500

Arrowhead Pharmaceuticals seeks Orphan Drug Designation for ARO-AAT

Banyan Biomarkers attained FDA’s De Novo request for Banyan BTI

Celgene Corporation asserted OTEZLA’s Phase II Clinical Trial data

Arterys sought FDA clearance for Oncology AI suite

Viz.ai sought De Novo FDA clearance for LVO strokes in CTA imaging

DreaMed Diabetics attained CE Mark for Platform tackling Type 1 diabetes